Insulin glargine in pediatric patients with type 1 diabetes in Japan

BACKGROUND: We evaluated the safety and effectiveness of insulin glargine in Japanese pediatric patients with type 1 diabetes in clinical settings based on post-marketing surveillance data. METHODS: Clinical data were collected from Japanese pediatric patients with type 1 diabetes for 24 weeks after...

Descripción completa

Detalles Bibliográficos
Autores principales: Urakami, Tatsuhiko, Naito, Yusuke, Seino, Yutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311442/
https://www.ncbi.nlm.nih.gov/pubmed/24840321
http://dx.doi.org/10.1111/ped.12379

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311442/
https://www.ncbi.nlm.nih.gov/pubmed/24840321
http://dx.doi.org/10.1111/ped.12379

Ejemplares similares